Terpenes — aroma, effects, profiles

Terpenes are the aromatic oils of the flower and, together with cannabinoids, define the effect profile. This hub gathers our terpene analyses and strain portraits.

We profile the twelve dominant terpenes on the Swiss market — myrcene, limonene, caryophyllene, pinene, linalool, terpinolene and more — and show how they shape the entourage effect together with CBD and THC. Each terpene has its own entity page with example strains.

Definition and context

Terpenes are volatile aromatic compounds that determine the scent and flavor of a strain. Myrcene, limonene, caryophyllene, pinene, and linalool are the most common in cannabis.

The situation in Switzerland

Since legal Swiss CBD flowers are barely allowed to differ in their cannabinoid profile, the terpene profile is the primary differentiator between strains and producers. Indoor cultivation with controlled drying preserves significantly more terpenes than fast-dried outdoor material.

What this means in practice

Terpenes are sensitive to heat: vaporizing at 180–200 °C preserves the profile, whereas combustion largely destroys it. Storing in glass jars at 55–62% relative humidity and protected from light keeps the aroma stable for months. If you choose a strain based on its effects, it makes more sense to look at the terpene profile rather than the simple Indica/Sativa label.

Frequently asked questions

Which terpene has a relaxing effect?

Myrcene and linalool are frequently associated with physical relaxation, while limonene and pinene are linked to a clear, alert sensation. Scientific research is still limited.

Does cannabis lose terpenes over time?

Yes. Light, heat, and air degrade terpenes—after a few months of open storage, the aroma becomes noticeably flatter.

Are terpenes included in the laboratory report?

Not always. A terpene profile requires an additional analysis; many certificates of analysis only display cannabinoids.

Background and development

In Switzerland, the scientific appreciation of terpenes has evolved alongside our unique legislative framework. Since the Federal Act on Narcotics and Psychotropic Substances (BetmG) was amended to allow cannabis with up to 1% THC, the domestic market has professionalized rapidly. Historically, the Federal Office of Public Health (FOPH/BAG) and Swissmedic focused strictly on cannabinoid thresholds. However, with medical THC by prescription officially legalized on 1 August 2022 and the launch of regulated pilot studies in Zurich, Basel, Bern, Lausanne, and Geneva, terpenes have taken center stage. These scientific trials require comprehensive laboratory profiles, shifting the focus from simple THC potency to complex secondary metabolites. Today, Swiss producers leverage state-of-the-art analytical testing to map terpene fingerprints. This structural shift from a grey-market commodity to a standardized product has established Switzerland as a pioneering European hub for terpene-focused research and consumer transparency.

Distinctions and misconceptions

A common misconception is confusing terpenes with cannabinoids like CBD, THC, or CBG. While cannabinoids are odorless compounds that interact directly with CB1 and CB2 receptors in the endocannabinoid system, terpenes are volatile aromatic hydrocarbons responsible for the plant's scent and nuance the overall experience. Another frequent point of confusion is flavonoids, which are distinct compounds primarily responsible for plant pigmentation and some antioxidant properties, rather than aroma. Consumers also frequently assume that Indica always smells earthy and Sativa always smells citrusy, or that these botanical categories dictate the biochemical effect. In reality, the specific terpene ratios, not the leaf morphology, govern the sensory and physical outcome. Additionally, some low-quality market products use cheap, synthetic, non-cannabis-derived food terpenes to mimic natural profiles. Authentic Swiss quality relies solely on native, flower-derived terpenes preserved through careful curing.

Decision guide for Switzerland

When selecting cannabis in Switzerland, adults should prioritize transparency and analytical data. First, demand a complete certificate of analysis (COA) from the producer. Reputable Swiss clubs and legal dispensaries provide detailed terpene profiles alongside cannabinoid percentages. Avoid products with suspiciously strong, uniform artificial scents, which often indicate post-harvest spraying with synthetic flavorings. Instead, seek out indoor-grown flowers cured slowly in temperature-controlled environments to preserve delicate volatile profiles. For legal adult consumption, ensure the total THC remains under the 1% BetmG threshold. Keep in mind that possession of up to 10 g of cannabis is decriminalized, though public consumption can carry a CHF 100 fixed penalty. Crucially, if you drive, Switzerland enforces a strict 1.5 µg/L blood THC limit, so choosing high-terpene, low-THC strains is a sensible approach. Opt for flower stored in dark violet glass jars rather than plastic bags to keep the aroma stable.

Do terpenes influence roadside drug testing or blood limits in Switzerland?

No, terpenes themselves are non-psychoactive and do not impact Swiss roadside saliva tests or the strict 1.5 micrograms per liter blood THC limit. However, the terpene profile can influence how you perceive the effects of legal CBD or low-THC cannabis. While terpenes are entirely legal and unregulated under the BetmG, you must still ensure the flowers you consume do not exceed the 1% total THC limit to remain compliant.

What is the difference between natural cannabis terpenes and added botanical terpenes?

Natural cannabis-derived terpenes are extracted directly from the flower, preserving the complex, authentic scent profile of the specific strain. Botanical terpenes are isolated from other plants, like lavender or pine, and sometimes added to distillate cartridges to mimic cannabis. While cheaper, these added botanicals lack the intricate synergistic compounds of native Swiss flower-derived profiles, which is why purists and Swiss club members consistently prefer naturally cured, single-source cannabis flowers.

Explore this topic further

These guides explain the background and address practical questions in the Swiss context.

Key figures

  • 220’000+ — Swiss adults regularly consume cannabis (BAG · Suchtmonitoring 2024)
  • 36% — of 15–34 year-olds have tried cannabis (EMCDDA · Country Report Switzerland 2024)
  • CHF 582M — estimated Swiss cannabis black-market revenue per year (Uni Genf · Cannabis Market Estimate 2023)
  • 7 — cities with active or approved pilot projects (BAG · Cannabis Pilotversuche 2026)

Current research

  • Cannabis use in Switzerland — Addiction Monitoring 2024 — Sucht Schweiz, BAG · 2024
  • European Drug Report — Cannabis Chapter — EMCDDA, EUDA · 2024
  • WHO Expert Committee on Drug Dependence — Cannabis Review — WHO ECDD, WHO · 2023